E- Resources

National Digital Health Mission and National Cancer Grid

The Mumbai sero-surveillance study: What does it mean?

Prof. Ullas Kolthur Department of Biological Sciences, Tata Institute of Fundamental Research, Mumbai

Mental health issues with COVID-19

Dr. Soumitra Pathare Consultant Psychiatrist and Director of Centre for Mental Health Law and Policy at Indian Law Society, Pune

Learning from experiences: How Massachusetts turned the tide with COVID-19

Dr. Noopur Raje Professor, Medicine, Harvard Medical School, Director, Multiple Myeloma Program, Medical Oncology, Massachusetts General Hospital

My experience with COVID

Dr. Nikita Mehra Assistant Professor, Department of Medical Oncology Cancer Institute, Adyar, Chennai

The Spectre of Comparison

Dr. Carlo Caduff Reader in Global Health and Social Medicine. Director of Postgraduate Research Studies and Chair of the Culture, Medicine and Power (CMP) research group. King’s College London

Research Priorities for COVID 19

Dr. S P Kalantri Director-Professor, Internal Medicine, MGIMS, Wardha

How a potentially explosive Dharavi Pandemic was averted

Mr Kiran Dighavkar Assistant Commissioner, G/ North Ward, Brihan Mumbai Muncipal Corporation (BMC)

Frontline heroes who worked to save their community

Miss. Zaberi Ansari, Mr. Kuna Kanase KIDS OF DHARAVI

Managing COVID-19 pandemic at a hospital level

Dr. Virkam Mathew MD, DM Professor & Head, Clinical Haematology, Christian Medical College, Vellore

Testing options for COVID-19

Dr. Raman Gangakhedkar Head Scientist, Epidemiology & Communicable Diseases National Institute of Virology, ICMR.

Treating COVID-19: What treatment do we know is effective, 6 months into the pandemic ?

Dr. Zarir Udwadia Consultant Pulmonologist, Hinduja Hospital & Breach Candy Hospital, Mumbai

The Why, How & What of Research during COVID era

Dr. S. P. Kalantri Director-Professor, Internal Medicine, MGIMS, Wardha

Current strategies concerning treatment and antibody testing in COVID 19

Dr. Soumya Swaminathan Chief Scientist, WHO Former Deputy Director-General, WHO

Overview, Strategy post lifting of restrictions, Update on antibody testing and vaccines

Dr. Gagandeep Kang Professor, Microbiology, CMC Vellore, Executive Director, THSTI, Delhi

Treatment of COVID 19

Dr. Shruti Tandon Consultant Intensivist, Jaslok Hospital, Mumbai

From the frontlines at Boston

Dr. Sundara Kumaran Boston Medical Center, Boston

Journey of Ayushman Bharat - Pradhan Mantri Jan Arogya Yojana (PM-JAY) covering 1 Crore treatments, & its role in COVID-19

Dr. Indu Bhushan Chief Executive Officer (CEO), AYUSHMAN BHARAT –PMJAY & National Health Authority, Govt. of India.

Public health perspectives on COVID-19, lockdown and its impact on non-COVID illnesses

Dr. Anant Bhan Researcher & Expert in Public Health & Bioethics

Overview of COVID-19, strategy during the extended lockdown and plan after the lockdown is lifted, antibody testing and the "Immuno Pass" strategy

Dr. Soumya Swaminathan Chief Scientist, World Health Organization

Treatment/ Management options on COVID -19

Dr. Ashit Hegde Consultant Physician & Intensivist, Head – Critical Care, Hinduja Hospital, Mumbai

Reflections from our recovered COVID-19 healthcare workers

Mr. Jackson and Dr. Anuj from TMH

Nurses as the backbone for Infection Prevention and Control - COVID-19 and beyond

Dr. Daniel VanderEnde MD, MPH, DTM&H, Medical Officer, International Infection Control Program, Office of the Director, Division of Healthcare Quality Promotion, CDC, New Delhi Office

Challenges posed by COVID-19 in Oncology Nursing

Ms. Sindhu Nair R.N, MSc (Oncology Nursing), Assistant Nursing Superintendent and Quality Manager (Nursing), Tata Memorial Hospital, Mumbai

Nursing Preparedness during COVID-19: The CMC Vellore experience

Dr. Premila Lee MSc, PhD (Nursing) Nursing Suprintendent, CMC Vellore

Sero Immunology, Test for immune passport & vaccine

Dr. Gagandeep Kang Professor, Microbiology, CMC Vellore, Executive Director, THSTI, Delhi

N95 masks: Choosing the right one, re-use and decontamination

Prof. Arnab Bhattacharya Tata Institute of Fundamental Research, Mumbai

Treatment options for COVID-19

Dr. O C Abraham Prof of Medicine and Infectious Diseases , CMC, Vellore

Diagnostic tests, pandemic spread and therapeutic options

Dr. Clifford Lane (Deputy Director, National Institute of Allergy and Infectious Disease, NIH USA and Dr Anthony Fauci's deputy)

Panorama of a pandemic - epidemiology of the COVID-19 infection

Dr. Jayaprakash Muliyil MD, MPH, PhD, Chairman, Scientific Advisory Committee of the National Institute of Epidemiology, Former Principal, Christian Medical College, Vellore

Clinical management of COVID-19 infection

Dr. George M. Varghese MD, PhD, FRCP, FIDSA, Professor & Head, Department of Infectious Diseases, Christian Medical College Vellore

Government and PSA perspective on COVID-19

Prof. K Vijayraghavan (Principal Scientific Advisor to PM)

Pooled testing and Anitbody tests

Dr. Gagandeep Kang Professor, Microbiology, CMC Vellore, Executive Director, THSTI, Delhi

Treatment options for COVID-19

Dr. Shruti Tandon Consultant Intensivist, Jaslok Hospital, Mumbai

Psychological aspects of the pandemic

Dr. Soumitra Pathare Director, Centre for Mental Health Law and Policy

Overview of COVID-19

Dr. Shahid Jameel (CEO DBT-Wellcome)

PPE - extended use & reuse

Dr. Daniel VanderEnde MD, MPH, DTM&H, Medical Officer, International Infection Control Program, Office of the Director,
Division of Healthcare Quality Promotion, CDC, New Delhi Office

WHO perspective & response

Dr. Soumya Swaminathan Chief Scientist, World Health Organization

NCG Guidelines for cancer care during COVID-19

Prof. Dr. Manju Sengar Professor, Medical Oncology, TMH , Mumbai

SARS-Cov-2 overview

Dr. Gagandeep Kang Professor, Microbiology, CMC Vellore, Executive director, THSTI, Delhi

Test Available for COVID-19

Dr. Camilla Rodrigues Head of Microbiology, Hinduja Hospital, Mumbai

Public health aspect and initiative

Prof. Giridhar Babu Professor of Public Health, Public Health Foundation of India (PHFI)

PPE Optimization & Reuse and Treatment Overview

Dr. Daniel VanderEnde MD, MPH, DTM&H, Medical Officer, International Infection Control Program,
Office of the Director, Division of Healthcare Quality Promotion, CDC, New Delhi Office

NCG guidelines for cancer care during COVID-19- draft version

Dr. Manju Sengar Professor, Medical Oncology, TMH, Mumbai

CMC vellore approach for COVID -19

Dr. Vikram Mathews Associate Director, CMC Vellore

Handling the Challenges faced in patient care in this pandemic (as an administrator)

Dr. Randeep Guleria Director, AIIMS New Delhi and Professor, Pulmonary Medicine

COVID-19 Outbreak

Dr. Sanjay Biswas Prof. & Head Dept of Microbiology, TMH, Mumbai

COVID-19 Overview in INDIA

Dr. Manju Sengar Professor, Medical Oncology, TMH , Mumbai

Importance of triage in hospital, How to conserve PPE

Dr. Daniel VanderEnde MD, MPH, DTM&H, Medical Officer, International Infection Control Program, Office of the Director,
Division of Healthcare Quality Promotion, CDC, New Delhi Office

COVID-19 Virologist's perspective

Dr. Gagandeep Kang Professor, Microbiology, CMC Vellore, Executive Director, THSTI, Delhi

Overview of REDCap

Dr. Indranil Mallick Consultant Radiation Oncologist Tata Medical Centre, Kolkata West Bengal

Oncology research in LMICs

Prof. Ian Tannock Emeritus Professor of Medicine and Medical Biophysics at Princess Margaret Cancer Centre
and University of Toronto

Can we believe what we read? How to evaluate reports of clinical studies

Prof. Ian Tannock Emeritus Professor of Medicine and Medical Biophysics at Princess Margaret Cancer Centre
and University of Toronto

Measuring and valuing health for cancer therapies

Prof. John Cairns Health Economics, London School of Hygiene and Tropical Medicine

Outcome Measures of Clinical Trials

Marc Buyse

The impact of Health Technology Assessment (HTA) in decision making in oncology

Francoise Cluzeau And Richard Sullivan

Principles of Health Technology Assessment in Oncology

Francis Ruiz and John Cairns Will

Time to Event (survival) analysis

Prof. Allan Hackshaw

Sample size considerations for comparative clinical trials

Mark Krailo

Essentials of Randomized Trials

Marc Buyse